참고문헌
- Arcamone, F. M., C. Bertazzoli, M. Ghione, and T. Scotti. 1959. Melanosporin and elaiophylin, new antibiotics from Streptomyces melanosporus (sive melanosporofaciens) n. sp. G. Microbiol. 7: 207-216.
- Asano, N. 2003. Glycosidase inhibitors: Update and perspectives on practical use. Glycobiology 13: 93-104. https://doi.org/10.1093/glycob/cwg090
-
De Melo, E. B., A. da Silveira Gomes, and I. Carvalho. 2006.
$\alpha$ - and$\beta$ -Glucosidase inhibitors: Chemical structure and biological activity. Tetrahedron 62: 10277-10302. https://doi.org/10.1016/j.tet.2006.08.055 - Dennis, J. W., S. Laferte, C. Waghorne, M. L. Breitman, and R. S. Kerbel. 1987. Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 236: 582-585. https://doi.org/10.1126/science.2953071
- Dettenhofer, M. and X. F. Yu. 2001. Characterization of the biosynthesis of human immunodeficiency virus type 1 Env from infected T-cells and the effects of glucose trimming of Env on virion infectivity. J. Biol. Chem. 276: 5985-5991. https://doi.org/10.1074/jbc.M008933200
- Dwek, R. A. 1995. Glycobiology: Towards understanding the function of sugars. Biochem. Soc. Trans. 23: 1-25. https://doi.org/10.1042/bst0230001
- Einfeld, D. 1996. Maturation and assembly of retroviral glycoproteins. Curr. Top. Microbiol. 214: 133-176.
- Fang, A., G. K. Wong, and A. L. Demain. 2000. Enhancement of the antifungal activity of rapamycin by the coproduced elaiophylin and nigericin. J. Antibiot. 53: 158-162. https://doi.org/10.7164/antibiotics.53.158
-
Fischer, P. B., M. Collin, G. B. Karlsson, W. James, T. D. Butters, S. J. Davis, S. Gordon, R. A. Dwek, and F. M. Platt. 1995. The
$\alpha$ -glucosidase inhibitor N-buthyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding. J. Virol. 69: 5791-5797. - Grigoriev, P. A., R. Schlegel, and U. Grafe. 2001. Cation selective ion channels formed by macrodiolide antibiotic elaiophylin in lipid bilayer membranes. Bioelectrochemistry 54: 11-15. https://doi.org/10.1016/S0302-4598(01)00102-7
- Gruters, R. A., J. J. Neefjes, M. Tersmette, R. E. de Goede, A. Tulp, H. G. Huisman, F. Miedema, and H. L. Ploegh. 1987. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature 330: 74-77. https://doi.org/10.1038/330074a0
- Hiebsch, R. R. and B. W. Wattenberg. 1992. Vesicle fusion in protein transport through the golgi in vitro does not involve long-lived prefusion intermediates. A reassessment of the kinetics of transport as measured by glycosylation. Biochemistry 31: 6111-6118. https://doi.org/10.1021/bi00141a022
- Jacob, G. S. 1995. Glycosylation inhibitors in biology and medicine. Curr. Opin. Struct. Biol. 5: 605-611. https://doi.org/10.1016/0959-440X(95)80051-4
- Johnson, V. A., B. D. Walker, M. A. Barlow, T. J. Paradis, T. C. Chou, and M. S. Hirsch. 1989. Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine. Antimicrob. Agents Chemother. 33: 53-57. https://doi.org/10.1128/AAC.33.1.53
- Lad, V. J. and A. K. Gupta. 2002. Inhibition of Japanese encephalitis virus maturation and transport in PS cells to cell surface by brefeldin A. Acta Virol. 46: 187-190.
-
Lee, D. S. and S. H. Lee. 2001. Genistein, a soy isoflavone, is a potent
$\alpha$ -glucosidase inhibitor. FEBS Lett. 501: 84-86. https://doi.org/10.1016/S0014-5793(01)02631-X - Lee, D. S., S. H. Lee, J. H. Woo, J. M. Lee, Y. B. Seu, and S. D. Hong. 1997. Antibacterial activities of methylelaiophylin. Korean J. Life Sci. 7: 180-185.
- Munniz, M. and H. Riezman. 2000. Intracellular transport of GPI-anchored proteins. EMBO J. 19: 10-15. https://doi.org/10.1093/emboj/19.1.10
- Muroi, M., A. Takasu, M. Yamasaki, and A. Takatsuki. 1993. Folimycin (concanamycin A), an inhibitor of V-type H(+)-ATPase, blocks cell-surface expression of virus-envelope glycoproteins. Biochem. Biophys. Res. Commun. 193: 999-1005. https://doi.org/10.1006/bbrc.1993.1724
-
Nakakoshi, M., N. Kimura, M. Yoshihama, and M. Uramoto. 1999. SNA-4606-1, a new member of elaiophylins with enzyme inhibition activity against testosterone 5
$\alpha$ -reductase. J. Antibiot. 52: 175-177. https://doi.org/10.7164/antibiotics.52.175 - Nakamura, M., Y. Kono, and A. Akatsuki. 2003. Mepanipyrim, a novel inhibitor of pharmacologically induced Golgi dispersion. Biosci. Biotechnol. Biochem. 67: 139-150. https://doi.org/10.1271/bbb.67.139
- Ohtsuka, S., S. Ueno, C. Yoshikumi, F. Hirose, Y. Ohmura, T. Wada, T. Fujii, and E. Takahashi. 1973. Polysaccharides having an anticarcinogenic effect and a method of producing them from species of Basidiomycetes. UK Patent 1331513, 26 September.
- Olkkonen, V. M. and E. Ikonen. 2006. When intracellular logistics fails - genetic defects in membrane trafficking. J. Cell Sci. 119: 5031-5045. https://doi.org/10.1242/jcs.03303
-
Papandreou, M. J., R. Barbouche, R. Guieu, M. P. Kieny, and E. Fenouillet. 2002. The
$\alpha$ -glucosidase inhibitor 1-deoxynojirimycin blocks human immunodeficiency virus envelope glycoprotein-mediated membrane fusion at the CXCR4 binding step. Mol. Pharmacol. 61: 186-193. https://doi.org/10.1124/mol.61.1.186 - Quinn, T. C. 2008. HIV epidemiology and the effects of antiviral therapy on long-term consequences. AIDS 22(Suppl 3): 7-12. https://doi.org/10.1097/01.aids.0000327510.68503.e8
- Sagiv, Y., A. Legesse-Miller, A. Porat, and Z. Elazar. 2000. GATE-16, a membrane transport modulator, interacts with NSF and the Golgi v-SNARE GOS-28. EMBO J. 19: 1494-1504. https://doi.org/10.1093/emboj/19.7.1494
- Segel, I. H. 1975. Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme System, pp. 100-202. Wiley, New York.
-
Tsujii, E., M. Muroi, N. Shiragami, and A. Takatsuki. 1996. Nectrisine is a potent inhibitor of
$\alpha$ -glucosidases, demonstrating activities similarly at enzyme and cellular levels. Biochem. Biophys. Res. Commun. 220: 459-466. https://doi.org/10.1006/bbrc.1996.0427
피인용 문헌
- Antiviral therapies targeting host ER alpha-glucosidases: Current status and future directions vol.99, pp.3, 2011, https://doi.org/10.1016/j.antiviral.2013.06.011
- Novel synthesis of dihydropyrimidines for α-glucosidase inhibition to treat type 2 diabetes: In vitro biological evaluation and in silico docking vol.54, pp.None, 2011, https://doi.org/10.1016/j.bioorg.2014.05.003
- Characterization of the biochemical, physiological, and medicinal properties of Streptomyces hygroscopicus ACTMS-9H isolated from the Amazon (Brazil) vol.101, pp.2, 2011, https://doi.org/10.1007/s00253-016-7886-9
- Characterization of the biochemical, physiological, and medicinal properties of Streptomyces hygroscopicus ACTMS-9H isolated from the Amazon (Brazil) vol.101, pp.2, 2011, https://doi.org/10.1007/s00253-016-7886-9
- Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis vol.23, pp.3, 2011, https://doi.org/10.3390/molecules23030563
- Synthesis, Molecular Modeling and Biological Evaluation of 5-arylidene-N,N-diethylthiobarbiturates as Potential α-glucosidase Inhibitors vol.15, pp.2, 2011, https://doi.org/10.2174/1573406414666180912114814
- Efomycins K and L From a Termite-Associated Streptomyces sp. M56 and Their Putative Biosynthetic Origin vol.10, pp.None, 2011, https://doi.org/10.3389/fmicb.2019.01739
- Natural Occurrence, Bioactivity and Biosynthesis of Elaiophylin Analogues vol.24, pp.21, 2011, https://doi.org/10.3390/molecules24213840
- An efficient and targeted synthetic approach towards new highly substituted 6-amino-pyrazolo[1,5- a ]pyrimidines with α -glucosidase inhibitory activity vol.10, pp.None, 2011, https://doi.org/10.1038/s41598-020-59079-z